330 related articles for article (PubMed ID: 28920169)
21. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients.
Qu J; L X; Liu Y; Wang X
Indian J Med Res; 2015 Mar; 141(3):315-21. PubMed ID: 25963492
[TBL] [Abstract][Full Text] [Related]
22. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
Wang Y; Zhang S; Li L; Xie J
Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
[TBL] [Abstract][Full Text] [Related]
23. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis.
Huang CT; Lee LN; Ho CC; Shu CC; Ruan SY; Tsai YJ; Wang JY; Yu CJ
J Infect; 2014 May; 68(5):440-7. PubMed ID: 24393650
[TBL] [Abstract][Full Text] [Related]
24. [Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia].
Fu Y; Jiang H; Li LX; Chen J; Zhang JL; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1296-300. PubMed ID: 24156453
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction.
Su L; Feng L; Song Q; Kang H; Zhang X; Liang Z; Jia Y; Feng D; Liu C; Xie L
Mediators Inflamm; 2013; 2013():969875. PubMed ID: 23935252
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia.
Aimoto M; Koh H; Katayama T; Okamura H; Yoshimura T; Koh S; Nanno S; Nishimoto M; Hirose A; Nakamae M; Nakane T; Nakamae H; Kakeya H; Hino M
Infection; 2014 Dec; 42(6):971-9. PubMed ID: 25038889
[TBL] [Abstract][Full Text] [Related]
27. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
[TBL] [Abstract][Full Text] [Related]
28. PCT and sTREM-1: the markers of infection in critically ill patients?
Schultz MJ; Determann RM
Med Sci Monit; 2008 Dec; 14(12):RA241-7. PubMed ID: 19043381
[TBL] [Abstract][Full Text] [Related]
29. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
30. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of serum procalcitonin, serum interleukin-6, and interleukin-8 as predictors of serious infection in children with febrile neutropenia and cancer.
Srinivasan A; Kumar N; Scott JX
Indian J Cancer; 2021; 58(2):185-189. PubMed ID: 33402576
[TBL] [Abstract][Full Text] [Related]
32. Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.
Korpelainen S; Intke C; Hämäläinen S; Jantunen E; Juutilainen A; Pulkki K
Dis Markers; 2017; 2017():9805609. PubMed ID: 28845081
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units.
Takahashi W; Nakada TA; Yazaki M; Oda S
Shock; 2016 Sep; 46(3):254-60. PubMed ID: 27172160
[TBL] [Abstract][Full Text] [Related]
34. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
35. Dynamic Monitoring of sTREM-1 and Other Biomarkers in Acute Cholangitis.
Jiang J; Wang X; Cheng T; Han M; Wu X; Wan H; DaojunYu
Mediators Inflamm; 2020; 2020():8203813. PubMed ID: 32508526
[TBL] [Abstract][Full Text] [Related]
36. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock.
Ríos-Toro JJ; Márquez-Coello M; García-Álvarez JM; Martín-Aspas A; Rivera-Fernández R; Sáez de Benito A; Girón-González JA
PLoS One; 2017; 12(4):e0175254. PubMed ID: 28380034
[TBL] [Abstract][Full Text] [Related]
37. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
38. Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients.
Li HX; Liu ZM; Zhao SJ; Zhang D; Wang SJ; Wang YS
J Int Med Res; 2014 Aug; 42(4):1050-9. PubMed ID: 24827825
[TBL] [Abstract][Full Text] [Related]
39. Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever.
Bilgir O; Bilgir F; Kebapcilar L; Bozkaya G; Çalan M; Kırbıyık H; Avci M; Sari İ; Yuksel A; Isikyakar T
Transfus Apher Sci; 2012 Feb; 46(1):19-24. PubMed ID: 22079264
[TBL] [Abstract][Full Text] [Related]
40. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
